The psoriatic arthritis treatment market value was USD 12.19 Billion in 2023, driven by the prevalence of psoriatic arthritis across the globe. The market size is anticipated to grow at a CAGR of 9.80% during the forecast period of 2024-2032 to achieve a value of USD 28.28 Billion by 2032.
Base Year
Historical Year
Forecast Year
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is estimated that psoriasis affects more than 125 million individuals around the globe, and psoriasis tends to create psoriatic arthritis in 30% of the population. The global industry for psoriatic arthritis treatment is influenced by an increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis.
Psoriatic arthritis is a chronic psoriasis-related degenerative disorder. Swollen fingers, toes, and tender joints, stiffness, lowered back pain, and pitted nails are prevalent symptoms of psoriatic arthritis. Psoriatic arthritis treatment market can be divided on the basis of segments like drug class, product type and administration route.
Market Breakup by Drug Class
Market Breakup by Route of Administration
Market Breakup by Drug Type
Market Breakup by Distribution Channel
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is driving the global psoriatic arthritis treatment industry. The other factors aiding in the growth of the industry are investments by major companies in clinical R&D, new product launches, increasing disease prevalence and proactive government initiatives. The factors such as high cost of treatment, stringent regulatory approval and adverse effect of drugs may hinder the growth of the market in coming future.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global psoriatic arthritis treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Route of Administration |
|
| Breakup by Drug Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The value for psoriatic arthritis treatment market attained a value of USD 12.19 Billion in 2023.
The market is expected to grow at a CAGR of 9.80% during the forecast period of 2024-2032, likely to attain a value of USD 28.28 Billion by 2032.
The major drivers of the market include the increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis, new product launches, growing disease prevalence, and rising government initiatives.
The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is the key industry trend propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading drug classes of psoriatic arthritis treatment in the industry are NSAIDs, DMARDs, and biologics, among others.
The significant product types in the market are prescription and OTC.
The major routes of administration of psoriatic arthritis treatment in the industry are topical, oral, and injectable.
The major players in the industry are AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., UCB SA, and AstraZeneca plc, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share